{"disease":{"id":"tumor-responses","name":"tumor responses"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03275376","title":"Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":34,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT03188497","title":"Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}